Tuesday, December 2, 2008 - 8:36PM EST

Review Articles

1. Palliative care in end-stage renal disease: illness trajectories, communication, and hospice use.

Author
Holley JL;
Institution
Department of Medicine, University of Illinois, Urbana-Champaign, and Carle Clinic, Urbana, IL 61801, USA. jean.holley@carle.com
Journal
Adv Chronic Kidney Dis. 2007 Oct;14(4):402-8.
Abstract URL
Click here to view abstract

2. Psychosocial and quality of life issues in women with end-stage renal disease.

Author
Lew SQ; Patel SS;
Institution
Department of Medicine, Division of Renal Diseases and Hypertension, George Washington University, Washington, DC, USA. sqlew@gwu.edu
Journal
Adv Chronic Kidney Dis. 2007 Oct;14(4):358-63.
Abstract URL
Click here to view abstract

3. Depression in end-stage renal disease patients: a critical review.

Author
Kimmel PL; Cukor D; Cohen SD; Peterson RA;
Institution
Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University, Washington, DC 20037, USA. pkimmel@mfa.gwu.edu
Journal
Adv Chronic Kidney Dis. 2007 Oct;14(4):328-34.
Abstract URL
Click here to view abstract

4. Technology insight: Innovative options for end-stage renal disease--from kidney refurbishment to artificial kidney.

Author
Braam B; Verhaar MC; Blankestijn P; Boer WH; Joles JA;
Institution
Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada. branko.braam@ualberta.ca
Journal
Nat Clin Pract Nephrol. 2007 Oct;3(10):564-72.
Abstract URL
Click here to view abstract

5. The association between blood pressure and mortality in ESRD-not different from the general population?

Author
Lacson E Jr; Lazarus JM;
Institution
Fresenius Medical Care, Waltham, Massachusetts, USA. elacsonj@fmc-na.com
Journal
Semin Dial. 2007 Nov-Dec;20(6):510-7.
Abstract URL
Click here to view abstract

6. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate.

Author
Sprague SM;
Institution
Division of Nephrology and Hypertension, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, IL 60201, USA. ssprague@northwestern.edu
Journal
Curr Med Res Opin. 2007 Dec;23(12):3167-75.
Abstract URL
Click here to view abstract

7. Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans.

Author
Agodoa L; Eggers P;
Institution
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA. agodoal@mail.nih.gov
Journal
Semin Dial. 2007 Nov-Dec;20(6):577-85.
Abstract URL
Click here to view abstract

8. Role of leptin in reverse epidemiology in chronic kidney disease.

Author
Scholze A; Tepel M;
Institution
Med. Klinik IV Nephrologie, Charite Campus Benjamin Franklin, Berlin, Germany.
Journal
Semin Dial. 2007 Nov-Dec;20(6):534-8.
Abstract URL
Click here to view abstract

9. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.

Author
Suliman ME; Lindholm B; Barany P; Qureshi AR; Stenvinkel P;
Institution
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
Journal
Semin Dial. 2007 Nov-Dec;20(6):523-9.
Abstract URL
Click here to view abstract

10. Nitric oxide, malnutrition and chronic renal failure.

Author
Brunini TM; Moss MB; Siqueira MA; Santos SF; Lugon JR; Mendes-Ribeiro AC;
Institution
Departamento de Farmacologia e Psicobiologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Journal
Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):155-61.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9